AII
TMCI icon

AGF Investments Inc’s Treace Medical Concepts TMCI Stock Holding History

AGF Investments Inc’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-492
Closed -$9K – 691
2021
Q4 		$9K Buy
+492
New +$10.2K ﹤0.01% 695

Other funds holding TMCI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AGF Investments Inc's TMCI Position: Q1 2022 in Review

AGF Investments Inc sold out of Treace Medical Concepts (TMCI) in Q1 2022, closing a stake of 492 shares — an estimated $9K sold.

AGF Investments Inc first reported a position in TMCI in Q4 2021 and held it in 1 quarter. The position peaked at $9K in Q4 2021. 75 funds tracked by Wall St. Rank hold TMCI as of Q1 2022.

  • AGF Investments Inc reported no remaining Treace Medical Concepts position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 492 Treace Medical Concepts shares in Q1 2022, an estimated $9K.
  • AGF Investments Inc first reported a position in Treace Medical Concepts in Q4 2021 and held it in 1 quarter.
  • AGF Investments Inc's Treace Medical Concepts position peaked at $9K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.